Evox Therapeutics Ltd is to use its exosome-based technology to work on prospective delivery approaches for an anti-infective drug from the Bill & Melinda Gates Foundation. Separately, the company also appointed Edwin Moses, the former Ablynx chief executive, as non-executive chairman of its board of directors.
